Xontogeny LLC 13D and 13G filings for Landos Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 4:50 pm Purchase |
2024-03-24 | 13D | Landos Biopharma, Inc. LABP |
Xontogeny LLC | 309,092 9.900% |
309,092 (New Position) |
Filing |